This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Asia Bio Partnering Forum
Marina Bay Sands Convention Center
April 24—25, 2024 | SingaporeApril 29—30, 2024 | Virtual

Fong Ming Koh
Principal at LYFE Capital


Dr Fong Ming Koh is a Principal at LYFE Capital, a global healthcare investment platform dedicated to advancing the healthcare landscape through strategic value creation. LYFE’s diverse investment portfolio spans the entire healthcare sector, encompassing therapeutics, medical devices, diagnostics, and emerging sub-sectors across North America and Asia. Prior to joining LYFE, Fong was the Head of Life Sciences at Heritas Capital, a Singapore-based healthcare-focused impact fund manager. A developmental biologist by training, he has extensive research experience spanning pluripotent stem cells, epigenetics and cancer. Dr Koh received his Ph.D. in Biomedical Sciences from the University of California, San Francisco.

Agenda Sessions

  • Asia Bio Partnering Forum Workshop Session 2: Fundraising and capital markets trends for Asia life sciences companies